Imaging-based PRediction of Eligibility for ChemoImmunotherapy in reSEctable NSCLC, iPRECISE

Clinical trial NCT07559123 · RECRUITING

Trial details

NCT number: NCT07559123
Sponsor: Samsung Medical Center
Status: RECRUITING
Study type: OBSERVATIONAL

NSCLC Neoadjuvant Chemoimmunotherapy CT

Start date: 2026-02-01
Primary completion: 2028-12-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.